Burning Rock Biotech Limited (BNR) Financial Statements
Burning Rock Biotech Limited (BNR) files with the U.S. Securities and Exchange Commission under CIK 0001792267. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2025
- Revenue
- 539.57 million CNY
- Net Income
- -55.35 million CNY
- Total Assets
- 820.38 million CNY
- Net Cash from Operations
- -28.44 million CNY
Fiscal year ended Dec 31, 2025. Latest periodic SEC filing: Apr 28, 2026. Source: SEC filings (EDGAR XBRL). Amounts in CNY.
Open the full financial statements for BNR in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History